These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33752673)

  • 1. Community acceptance of reactive focal mass drug administration and reactive focal vector control using indoor residual spraying, a mixed-methods study in Zambezi region, Namibia.
    Roberts KW; Smith Gueye C; Baltzell K; Ntuku H; McCreesh P; Maglior A; Whittemore B; Uusiku P; Mumbengegwi D; Kleinschmidt I; Gosling R; Hsiang MS
    Malar J; 2021 Mar; 20(1):162. PubMed ID: 33752673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial.
    Hsiang MS; Ntuku H; Roberts KW; Dufour MK; Whittemore B; Tambo M; McCreesh P; Medzihradsky OF; Prach LM; Siloka G; Siame N; Gueye CS; Schrubbe L; Wu L; Scott V; Tessema S; Greenhouse B; Erlank E; Koekemoer LL; Sturrock HJW; Mwilima A; Katokele S; Uusiku P; Bennett A; Smith JL; Kleinschmidt I; Mumbengegwi D; Gosling R
    Lancet; 2020 Apr; 395(10233):1361-1373. PubMed ID: 32334702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia.
    Medzihradsky OF; Kleinschmidt I; Mumbengegwi D; Roberts KW; McCreesh P; Dufour MK; Uusiku P; Katokele S; Bennett A; Smith J; Sturrock H; Prach LM; Ntuku H; Tambo M; Didier B; Greenhouse B; Gani Z; Aerts A; Gosling R; Hsiang MS
    BMJ Open; 2018 Jan; 8(1):e019294. PubMed ID: 29374672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the low endemic setting of Namibia: an analysis alongside a 2×2 factorial design cluster randomised controlled trial.
    Ntuku H; Smith-Gueye C; Scott V; Njau J; Whittemore B; Zelman B; Tambo M; Prach LM; Wu L; Schrubbe L; Kang Dufour MS; Mwilima A; Uusiku P; Sturrock H; Bennett A; Smith J; Kleinschmidt I; Mumbengegwi D; Gosling R; Hsiang M
    BMJ Open; 2022 Jun; 12(6):e049050. PubMed ID: 35738650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "We were afraid of the lion that has roared next to us"; community response to reactive focal mass drug administration for malaria in Eswatini (formerly Swaziland).
    Baltzell KA; Maglior A; Bangu K; Mngadi N; Prach LM; Whittemore B; Ntshalintshali N; Saini M; Dlamini N; Kunene S; Hsiang MS
    Malar J; 2019 Jul; 18(1):238. PubMed ID: 31307494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: Results from a secondary analysis of a cluster randomised trial.
    Wu L; Hsiang MS; Prach LM; Schrubbe L; Ntuku H; Dufour MK; Whittemore B; Scott V; Yala J; Roberts KW; Patterson C; Biggs J; Hall T; Tetteh KKA; Gueye CS; Greenhouse B; Bennett A; Smith JL; Katokele S; Uusiku P; Mumbengegwi D; Gosling R; Drakeley C; Kleinschmidt I
    EClinicalMedicine; 2022 Feb; 44():101272. PubMed ID: 35198913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial.
    Vilakati S; Mngadi N; Benjamin-Chung J; Dlamini N; Dufour MK; Whittemore B; Bhangu K; Prach LM; Baltzell K; Nhlabathi N; Malambe C; Dlamini B; Helb D; Greenhouse B; Maphalala G; Pindolia D; Kalungero M; Tesfa G; Gosling R; Ntshalintshali N; Kunene S; Hsiang MS
    BMJ Glob Health; 2021 Jun; 6(6):. PubMed ID: 34193475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community facilitators and barriers to a successful implementation of mass drug administration and indoor residual spraying for malaria prevention in Uganda: a qualitative study.
    Wanzira H; Naiga S; Mulebeke R; Bukenya F; Nabukenya M; Omoding O; Echodu D; Yeka A
    Malar J; 2018 Dec; 17(1):474. PubMed ID: 30558632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community knowledge and acceptance of indoor residual spraying for malaria prevention in Mozambique: a qualitative study.
    Magaço A; Botão C; Nhassengo P; Saide M; Ubisse A; Chicumbe S; Zulliger R
    Malar J; 2019 Jan; 18(1):27. PubMed ID: 30683091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the acceptability and feasibility of reactive drug administration for malaria elimination in a Plasmodium vivax predominant setting: a qualitative study in two provinces in Thailand.
    Suwannarong K; Cotter C; Ponlap T; Bubpa N; Thammasutti K; Chaiwan J; Finn TP; Kitchakarn S; Mårtensson A; Baltzell KA; Hsiang MS; Lertpiriyasuwat C; Sudathip P; Bennett A
    BMC Public Health; 2023 Jul; 23(1):1346. PubMed ID: 37438774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploratory study of the acceptability of indoor residual spraying for malaria control in upper western Ghana.
    Suuron VM; Mwanri L; Tsourtos G; Owusu-Addo E
    BMC Public Health; 2020 Apr; 20(1):465. PubMed ID: 32252714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of the Plasmodium falciparum malaria epidemic in Kavango and Zambezi regions of Namibia in 2016.
    Chanda E; Arshad M; Khaloua A; Zhang W; Namboze J; Uusiku P; Angula AH; Gausi K; Tiruneh D; Islam QM; Kolivras K; Haque U
    Trans R Soc Trop Med Hyg; 2018 Dec; 112(12):546-554. PubMed ID: 30252108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional analysis of ITN and IRS coverage in Namibia in 2013.
    Allcock SH; Young EH; Sandhu MS
    Malar J; 2018 Jul; 17(1):264. PubMed ID: 30012154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial clustering of patent and sub-patent malaria infections in northern Namibia: Implications for surveillance and response strategies for elimination.
    Smith JL; Auala J; Tambo M; Haindongo E; Katokele S; Uusiku P; Gosling R; Kleinschmidt I; Mumbengegwi D; Sturrock HJW
    PLoS One; 2017; 12(8):e0180845. PubMed ID: 28820883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability and perceived barriers to reactive focal mass drug administration in the context of a malaria elimination program in Magude district, Southern Mozambique: A qualitative study.
    Cuinhane CE; Galatas B; Lopez JM; Djive H; Nhantumbo H; Murato I; Saúte F; Aide P; Munguambe K; Torres N
    PLoS One; 2023; 18(3):e0283160. PubMed ID: 37000890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a correlation between malaria incidence and IRS coverage in western Zambezi region, Namibia?
    Mumbengegwi DR; Sturrock H; Hsiang M; Roberts K; Kleinschmidt I; Nghipumbwa M; Uusiku P; Smith J; Bennet A; Kizito W; Takarinda K; Ade S; Gosling R
    Public Health Action; 2018 Apr; 8(Suppl 1):S44-S49. PubMed ID: 29713594
    [No Abstract]   [Full Text] [Related]  

  • 17. Baseline characterization of entomological drivers of malaria transmission in Namibia: a targeted operational entomological surveillance strategy.
    Lukubwe O; Mwema T; Joseph R; Maliti D; Iitula I; Katokele S; Uusiku P; Walusimbi D; Ogoma SB; Gueye CS; Vajda E; Tatarsky A; Thomsen E; Tambo M; Mumbengegwi D; Lobo NF
    Parasit Vectors; 2023 Jul; 16(1):220. PubMed ID: 37408058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community acceptability to antimalarial mass drug administrations in Magude district, Southern Mozambique: A mixed methods study.
    Galatas B; Nhantumbo H; Soares R; Djive H; Murato I; Simone W; Macete E; Rabinovich NR; Alonso P; Candrinho B; Saúte F; Aide P; Munguambe K
    PLoS One; 2021; 16(3):e0249080. PubMed ID: 33755685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What drives community adherence to indoor residual spraying (IRS) against malaria in Manhiça district, rural Mozambique: a qualitative study.
    Munguambe K; Pool R; Montgomery C; Bavo C; Nhacolo A; Fiosse L; Sacoor C; Nhalungo D; Mabunda S; Macete E; Alonso P
    Malar J; 2011 Nov; 10():344. PubMed ID: 22111698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.